Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Van den Eynde

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|May 11, 2004
[A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase]B Van den Eynde
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|October 10, 2002
[Identification of cancer antigens of relevance for specific cancer immunotherapy]B van den Eynde
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 15, 2008
[Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy]B Van den Eynde
Current Opinion in Immunology|October 1, 1995
New tumor antigens recognized by T cellsB Van den Eynde, V G Brichard
Current Opinion in Immunology|October 1, 1992
Molecular definition of tumor antigens recognized by T lymphocytesP van der Bruggen, B Van den Eynde
Immunology Today|June 1, 1997
Tumor antigens recognized by T cellsT Boon, P G Coulie, B Van den Eynde
Biology of the Cell|January 1, 1994
Identification and characterization of the tumor-specific P1A gene productA Amar-Costesec, D Godelaine, B Van den Eynde, et al.
The Journal of Experimental Medicine|June 1, 1996
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinomaD Brändle, F Brasseur, P Weynants, et al.
The Journal of Biological Chemistry|April 3, 1999
A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cellsM Ayyoub, H Mazarguil, B Monsarrat, et al.
European Journal of Immunology|September 1, 1992
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptideB Lethé, B van den Eynde, A van Pel, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|May 11, 2004
[A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase]B Van den Eynde
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|October 10, 2002
[Identification of cancer antigens of relevance for specific cancer immunotherapy]B van den Eynde
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|April 15, 2008
[Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy]B Van den Eynde
Current Opinion in Immunology|October 1, 1995
New tumor antigens recognized by T cellsB Van den Eynde, V G Brichard
Current Opinion in Immunology|October 1, 1992
Molecular definition of tumor antigens recognized by T lymphocytesP van der Bruggen, B Van den Eynde
Immunology Today|June 1, 1997
Tumor antigens recognized by T cellsT Boon, P G Coulie, B Van den Eynde
Biology of the Cell|January 1, 1994
Identification and characterization of the tumor-specific P1A gene productA Amar-Costesec, D Godelaine, B Van den Eynde, et al.
The Journal of Experimental Medicine|June 1, 1996
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinomaD Brändle, F Brasseur, P Weynants, et al.
The Journal of Biological Chemistry|April 3, 1999
A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cellsM Ayyoub, H Mazarguil, B Monsarrat, et al.
European Journal of Immunology|September 1, 1992
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptideB Lethé, B van den Eynde, A van Pel, et al.
Pageof 4